A detailed history of Vaughan David Investments LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Vaughan David Investments LLC holds 309,437 shares of JNJ stock, worth $45.3 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares
309,437
Previous 307,565 0.61%
Holding current value
$45.3 Million
Previous $45 Million 11.55%
% of portfolio
1.15%
Previous 1.14%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$145.48 - $167.38 $272,338 - $313,335
1,872 Added 0.61%
309,437 $50.1 Million
Q2 2024

Aug 07, 2024

BUY
$144.38 - $157.78 $685,949 - $749,612
4,751 Added 1.57%
307,565 $45 Million
Q1 2024

May 13, 2024

BUY
$155.22 - $162.74 $99,185 - $103,990
639 Added 0.21%
302,814 $47.9 Million
Q4 2023

Jan 29, 2024

BUY
$145.6 - $158.88 $442,915 - $483,312
3,042 Added 1.02%
302,175 $47.4 Million
Q3 2023

Nov 07, 2023

BUY
$155.75 - $174.48 $474,726 - $531,815
3,048 Added 1.03%
299,133 $46.6 Million
Q2 2023

Aug 02, 2023

BUY
$154.35 - $166.11 $250,664 - $269,762
1,624 Added 0.55%
296,085 $49 Million
Q1 2023

May 02, 2023

BUY
$151.05 - $180.26 $92,291 - $110,138
611 Added 0.21%
294,461 $45.6 Million
Q4 2022

Feb 07, 2023

BUY
$160.2 - $179.79 $34,763 - $39,014
217 Added 0.07%
293,850 $51.9 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $602,890 - $670,866
3,737 Added 1.29%
293,633 $48 Million
Q2 2022

Aug 11, 2022

BUY
$168.19 - $186.01 $82,076 - $90,772
488 Added 0.17%
289,896 $51.5 Million
Q1 2022

May 09, 2022

BUY
$158.14 - $179.59 $191,507 - $217,483
1,211 Added 0.42%
289,408 $51.3 Million
Q4 2021

Feb 10, 2022

BUY
$155.93 - $173.01 $579,747 - $643,251
3,718 Added 1.31%
288,197 $49.3 Million
Q3 2021

Nov 04, 2021

SELL
$161.5 - $179.47 $372,419 - $413,857
-2,306 Reduced 0.8%
284,479 $45.9 Million
Q2 2021

Aug 11, 2021

BUY
$159.48 - $171.07 $581,304 - $623,550
3,645 Added 1.29%
286,785 $47.2 Million
Q1 2021

May 14, 2021

SELL
$153.07 - $170.48 $235,574 - $262,368
-1,539 Reduced 0.54%
283,140 $46.5 Million
Q4 2020

Feb 12, 2021

BUY
$137.11 - $157.38 $14,122 - $16,210
103 Added 0.04%
284,679 $44.8 Million
Q3 2020

Nov 12, 2020

SELL
$140.38 - $153.83 $55,028 - $60,301
-392 Reduced 0.14%
284,576 $42.4 Million
Q2 2020

Aug 07, 2020

BUY
$128.81 - $155.51 $242,549 - $292,825
1,883 Added 0.67%
284,968 $40.1 Million
Q1 2020

May 13, 2020

BUY
$111.14 - $153.99 $226,947 - $314,447
2,042 Added 0.73%
283,085 $37.1 Million
Q4 2019

Feb 13, 2020

SELL
$127.5 - $146.44 $15,300 - $17,572
-120 Reduced 0.04%
281,043 $41 Million
Q3 2019

Nov 13, 2019

BUY
$126.95 - $142.14 $233,207 - $261,111
1,837 Added 0.66%
281,163 $36.4 Million
Q2 2019

Aug 14, 2019

SELL
$131.15 - $144.24 $61,115 - $67,215
-466 Reduced 0.17%
279,326 $38.9 Million
Q1 2019

May 08, 2019

BUY
$125.72 - $139.79 $304,996 - $339,130
2,426 Added 0.87%
279,792 $39.1 Million
Q4 2018

Feb 08, 2019

SELL
$122.84 - $147.84 $1.59 Million - $1.91 Million
-12,920 Reduced 4.45%
277,366 $35.8 Million
Q3 2018

Nov 13, 2018

SELL
$121.58 - $142.88 $768,385 - $903,001
-6,320 Reduced 2.13%
290,286 $40.1 Million
Q2 2018

Aug 14, 2018

BUY
$119.4 - $131.76 $473,301 - $522,296
3,964 Added 1.35%
296,606 $36 Million
Q1 2018

May 04, 2018

BUY
$125.1 - $148.14 $583,841 - $691,369
4,667 Added 1.62%
292,642 $37.5 Million
Q4 2017

Feb 13, 2018

BUY
$131.22 - $143.62 $511,495 - $559,830
3,898 Added 1.37%
287,975 $40.2 Million
Q3 2017

Nov 09, 2017

BUY
$129.47 - $135.38 $14 Million - $14.7 Million
108,474 Added 61.77%
284,077 $36.9 Million
Q3 2017

Nov 08, 2017

SELL
$129.47 - $135.38 $14.6 Million - $15.2 Million
-112,518 Reduced 39.05%
175,603 $20.7 Million
Q2 2017

Aug 14, 2017

BUY
N/A
288,121
288,121 $38.1 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $383B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Vaughan David Investments LLC Portfolio

Follow Vaughan David Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vaughan David Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vaughan David Investments LLC with notifications on news.